VOLUME 9 NUMBER 3 • SEPTEMBER 2012
119
SA JOURNAL OF DIABETES & VASCULAR DISEASE
REVIEW
lipoprotein and coronary heart disease: A prospective case-control study.
Lancet
1977
1
: 965–970.
Somova LI, Nadar A, Rammanan P, Shode FO. Cardiovascular, antihyperlipidemic
35.
and antioxidant effects of oleanolic and ursolic acids in experimental hypertension.
Phytomedicine
2003;
10
: 115
Zimbabwe
121.
Somova LI, Shode FO, Ramnanan P, Nadar A. Antihypertensive, antiathersoclerotic
36.
and antioxidant activity of triterpenoids isolated from
Olea europaea
,
subspecies
africana leaves.
J Ethnopharmacol
2003;
84
: 299–305.
Gelfand M, Mavi S, Drummond RB, Ndemera B.
37.
The Traditional Medical Practitioner
in Zimbabwe: His Principles of Practice and Pharmacopoeia.
Gweru, Zimbabwe:
Mambo Press, 1985.
Musabayane CT, Munjeri O, Mdege ND. Effects of
38.
Helichrysum ceres
extracts on
renal function and blood pressure in the rat.
Renal Failure
2003;
25
: 5
Zimbabwe
14.
Musabayane CT, Kamadyaapa DR, Gondwe M, Moodley K, Ojewole JAO.
39.
Cardiovascular effects of
Helichrysum ceres
S. Moore [Asteraceae] leaf ethanolic
extract in experimental animal paradigms.
Cardiovasc J Afr
2008;
19
(5): 246–253.
Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic
40.
nephropathy.
Nephron Physiol
2007;
106
: 26–31.
Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H. Roles of the
41.
receptor for advanced glycation endproducts in diabetes-induced vascular injury.
J
Pharmacol Sci
2005;
97
: 305–311.
Mason RM, Wahab NA. Extra-cellular matrix metabolism in diabetic nephropathy.
42.
J
Am Soc Nephrol
2003;
14
: 1358–1373.
Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, Viberti G. Mechanical
43.
stretch induces vascular permeability factor in human mesangial cells: Mechanisms
of signal transduction.
Proc Nat Acad Sci (USA)
1997;
94
: 12112–12116.
Bickel CA, Knepper MA, Verbalis JG, Ecelbarger CA. Dysregulation of renal salt
44.
and water transport proteins in diabetic Zucker rats.
Kidney Int Suppl
2002;
61
:
2099–2110.
Anderson S, Vora JP. Current concepts of renal hemodynamics in diabetes.
45.
J
Diabetes Complications
1995;
9
: 304–307.
Ihara Y, Egashira K, Nakano K, Ohtani K, Kubo M, Koga J,
46.
et al
.
Upregulation of
the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the
pathogenesis of diabetic atherosclerosis.
J Mol Cell Cardiol
2007;
43
: 455–464.
Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R,
47.
et al.
Accelerated
nephropathy in diabetic apolipoprotein E-knockout mouse: Role of advanced
glycation.
J Am Soc Nephrol
2004;
15
: 2125–2138.
Hartog JW, Voors AA, Bakker SJ, Smit AJ, van Veldhuisen DJ. Advanced glycation
48.
end-products (AGEs) and heart failure: pathophysiology and clinical implications.
Eur J Heart Fail
2007;
9
: 1146–1155.
Tanaka Y, Uchino H, Shimizu T, Yoshii H, Niwa M, Ohmura C,
49.
et al
.
Effect of
metformin on advanced glycation endproduct formation and peripheral nerve
function in streptozotocin-induced diabetic rats.
Eur J Pharmacol
1999;
376
(1–2):
17–22.
Sheetz MJ, King GL. Molecular understanding of hyperglycaemia’s adverse effects
50.
for diabetes complications.
J Am Med Assoc
2002;
288
: 2579–2588.
Rahbar S, Figarola JL. Novel inhibitors of advanced glycation end-products.
51.
Arch
Biochem Biophys
2003;
419
: 63–79.
Rahbar S, Yerneni KK, Scott S, Gonzales N, Lalezari I. Novel inhibitors of advanced
52.
glycation endproducts (part II).
Mol Cell Biol Res Commun
2000;
3
(6): 360–366.
Kim H, Kang KS, Yamabe N, Nagai R, Yokozawa, T. Protective effect of heat-
53.
processed American ginseng against diabetic renal damage in rats.
J Agric Food
Chem
2007;
55
: 8491–8497.
Kim JD, Kang SM, Park MY, Jung TY, Choi HY, Ku SW. Ameliorative anti-diabetic
54.
activity of Dangnyosoko, a Chinese herbal medicine in diabetic rats.
Bioscience,
Biotechnol Biochem
2007;
71
(6): 1527–1534.
Kim SW, Jeon YS, Lee JU, Kang DG, Kook H, Ahn KY,
55.
et al.
Diminished adenylate
cyclase activity and aquaporin 2 expression in acute renal failure rats.
Kidney Int
2000;
57
(4): 1239–1417.
Wirasathiena L, Pengsuparpa T, Suttisria R, Uedab H, Moriyasub M, Kawanishib
56.
K. Inhibitors of aldose reductase and advanced glycation end-products formation
from the leaves of
Stelechocarpus cauliflorus
R.E. Fr.
Phytomedicine
2007;
14
:
546–550.
Atlas of End-Stage Renal Disease in the United States. Excerpts from the United
57.
States Renal Data Systems 2002 annual report.
Am J Kidney Dis
2003;
41
(4):
S7–254.
Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease.
58.
With emphasis on the stage of incipient diabetic nephropathy.
Diabetes 32 Suppl
1983;
2
: 64–78.
Arije A, Kadiri S, Akinkugbe OO. The viability of hemodialysis as a treatment option
59.
for renal failure in a developing economy.
Afr J Med Med Sci
2000;
29
: 311–314.
Marles R, Farnsworth N. Plants as sources of antidiabetic agents. In: Wagner H,
60.
Farnsworth NR (eds).
Economic and Medicinal Plant Research.
UK: Academic Press
Ltd, 1994;
6
: 146–187.
Wang XM, Guan SH, Liu RX, Sun JH, Liang Y, Yang M, W
61.
et al
.
HPLC determination
of four triterpenoids in rat urine after oral administration of total triterpenoids
from
Ganoderma lucidum . J Pharmaceut Biomed Anal
2007;
43
: 1185–1190.
Nakagawa T, Goto H, Hikiami H, Yokozawa T, Shibahara N, Shimada Y. Protective
62.
effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob
rats
Jf Ethnopharmacol
2007;
110
: 311–317.
Mapanga RF, Tufts MA, Shode FO, Musabayane CT. Renal effects of plant-derived
63.
oleanolic acid in streptozotocin-induced diabetic rats.
Renal Failure
2009;
31
(6):
481–491.
Yokozawa T, Yamabe N, Kim HY, Kang KS, Hur JM, Park CH, Tanaka T. Protective
64.
effects of morroniside isolated from
Corni Fructus
against renal damage in
streptozotocin-induced diabetic rats.
Biol Pharm Bull
2008;
31
: 1422–1428.
Rao NK, Nammi S. Antidiabetic and renoprotective effects of the chloroform
65.
extract of
Terminalia chebula
Retz. Seeds in streptozotocin-induced diabetic rats.
BMC Complement Alternative Med
2006;
6
: 17.
Musabayane C, Tufts MA, Mapanga RF. Synergistic antihyperglycemic effects
66.
between plant-derived oleanolic acid and insulin in streptozotocin-induced
diabetic rats.
Renal Failure
2010;
32
: 832–839.
Al-Qattan K, Thomson M, Ali M. Garlic
67.
(
Allium sativum)
and ginger
(
Zingiber
officinale)
attenuate structural nephropathy progression in streptozotocin-
induced diabetic rats.
Eur e-J Clin Nutr Metab
2008;
3
:
e62–e71.
Eidi A, Eidi M, Esmaeili E. Antidiabetic effect of garlic (Allium sativum L.) in normal
68.
and streptozotocin-induced diabetic rats.
Phytomedicine
2005;
13
: 624–629.
Ugochukwu NH, Cobourne MK. Modification of renal oxidative stress and lipid
69.
peroxidation in streptozotocin-induced diabetic rats treated with extracts from
Gongronema latifolium
leaves.
Clin Chim Acta
2003;
336
: 73–81.
El-Hilaly J, Hmammouchib M, Lyoussi B. Ethnobotanical studies and economic
70.
evaluation of medicinal plants in Taounate province (Northern Morocco).
J
Ethnopharmacol
2003;
86
: 149–158
Tabassum M, Mumtaz M, Haleem MA. Electrolyte content of serum, erythrocyte,
71.
kidney and heart tissue in salt induced hypertensive rats.
Life Sci
1996;
59:
731–
747.
Bwititi P, Musabayane CT, Nhachi CFB. Effects of
72.
Opuntia megacantha
on blood
glucose and kidney function in streptozotocin diabetic rats.
J Ethnopharmacol
2000;
69
(3): 247–252.
Bwititi PT, Machakaire T, Nhachi CB, Musabayane CT. Effects of
73.
Opuntiamegacantha
leaves extract on renal electrolyte and fluid handling in streptozotocin (STZ)-diabetic
rats.
Renal Failure
2001;
23
: 149–158.
Prince PS, Menon VP, Pari L. Hypoglycaemic activity of
74.
Syzigium cumini
seeds: effect
on lipid peroxidation in alloxandiabetic rats.
J Ethnopharmacol
1998;
61
:
l–7.
Braca A, Politi M, Sanogo R, Sanou H, Morelli I, Pizza CN. Chemical composition
75.
and antioxidant activity of phenolic compounds from wild and cultivated
Sclerocarya birrea
(
Anacardiaceae) leaves.
J Agric Food Chem
2003;
51
(23):
6689–6695.
Afzal M, KhanNA, GhufranA, Iqbal A, InamuddinM. Diuretic and nephroprotective
76.
effect of Jawarish Zarooni Sada – a polyherbal unani formulation.
J Ethnopharmacol
2004;
91
(2–3): 219–223.
Yasir M, Das S, Kharya MD. The phytochemical and pharmacological profile of
77.
Persea americana
Mill.
Phcog Rev
2010;
4
: 77–84.
Owolabi MA, Coker HAB, Jaja SI. Bioactivity of the phytoconstituents of the
78.
leaves of
Persea americana. Journal of Medicinal Plants Research
2010;
4
(12):
1130–1135.
Musabayane CT, Xozwa K, Ojewole JAO. Effects of
79.
Hypoxis hemerocallidea
(
Fisch.
&
C.A. Mey) [Hypoxidaceae] corm (African Potato) aqueous extract on renal
electrolyte and fluid handling in the rat.
Renal Failure
2005;
27
(5): 763–770.
Ojewole JAO. Antinociceptive, anti-inflammatory and antidiabetic properties of
80.
Hypoxis hemerocallidea
Fisch. & C.A. Mey. (Hypoxidaceae) corm [African Potato]
aqueous extract in mice and rats.
J Ethnopharmacol
2006;
103
(1): 126–134.
Usman H, Abdulrahman F, Usman A. Qualitative phytochemical screening and
81.
in vitro antimicrobial effects of methanol stem bark extract of
Ficus thonningii
(
Moraceae).
Afr J Tradit Complement Altern Med
2009;
6
(3): 289–295.
Benavente-Garcia O, Castillo J, Lorente J, Ortuno A, Del Rio JA. Antioxidant
82.
activity of phenolics extracted from
Olea europaea
L. leaves
Food Chem
2000;
68
: 457–462.
Bennani-Kabchi N, Fdhil H, Cherrah Y, El Bouayadi F, Kehel L, Marquie G.
83.
Therapeutic effect of
Olea europea
var. oleaster leaves on carbohydrate and lipid
metabolism in obese and prediabetic sand rats
(
Psammomys obesus) Ann Pharm
Fr
2000;
58
: 271–277.
Al-Azzawie HF, Alhamdani MS. Hypoglycemic and antioxidant effect of oleuropein
84.
in alloxan-diabetic rabbits
Life Sci
2006;
78
: 1371–1377.
Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent
85.
vasorelaxation caused by various plant extracts.
J Cardiovas Pharmacol
1995;
26
:
90–95.
